Search Results 31-40 of 20707 for B cell lymphomas
In MZL, changes happen that turn the B lymphocytes into cancer cells. The cancer cells can grow in the lymph nodes, bone marrow, stomach, spleen and other parts ...
It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...
Mayo Clinic doctors and researchers are studying B-cell lymphomas to look for new ways to improve diagnosis and treatment for this cancer. Cancer research is ...
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy · Overview · Participation ...
It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with follicular lymphoma. Venetoclax ...
Treatment for T-cell lymphomas may include a "watch and wait" approach, chemotherapy, immunotherapy, radiation therapy, targeted therapy, clinical trials, and ...
A complete blood count may be used to count the number of lymphocytes in a blood sample. A high number of B cells, one type of lymphocyte, could mean small ...
In a study of axicabtagene ciloleucel (axi-cel) CAR-T cell therapy for relapsed or refractory aggressive B-cell lymphoma, 30-day responses were comparable ...
Learn about this type of cancer that starts in the white blood cells and affects the skin. Treatment options include surgery, radiation and chemotherapy.
Mayo Clinic offers chimeric antigen receptor (CAR)-T cell therapy for people with certain types of B-cell non-Hodgkin lymphoma. This treatment, offered through ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.